Cellosaurus A549 EML4-ALK (CVCL_JK07)
| Cell line name | A549 EML4-ALK | ||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Synonyms | EML4-ALK Fusion-A549 Isogenic Cell Line | ||||||||||||||||||
| Accession | CVCL_JK07 | ||||||||||||||||||
| Resource Identification Initiative | To cite this cell line use: A549 EML4-ALK (RRID:CVCL_JK07) | ||||||||||||||||||
| Comments | Population: Caucasian. Characteristics: An EML4-ALK4 fusion was generated by CRISPR/Cas9. Characteristics: More sensitive to the ALK inhibitor crizotinib when compared to the parental cell line. Can be a useful model to study tyrosine kinase signaling pathway and to screen ALK inhibitors. Doubling time: ~25 hours (ATCC=CCL-185IG). Derived from site: In situ; Lung; UBERON=UBERON_0002048. | ||||||||||||||||||
| Sequence variations |
| ||||||||||||||||||
| Disease | Lung adenocarcinoma (NCIt: C3512) | ||||||||||||||||||
| Species of origin | Homo sapiens (Human) (NCBI Taxonomy: 9606) | ||||||||||||||||||
| Hierarchy | Parent: CVCL_0023 (A-549) Children:
| ||||||||||||||||||
| Sex of cell | Male | ||||||||||||||||||
| Age at sampling | 58Y | ||||||||||||||||||
| Category | Cancer cell line | ||||||||||||||||||
| STR profile | Source(s): ATCC=CCL-185IG Markers:
Run an STR similarity search on this cell line | ||||||||||||||||||
| Publications | CLPUB00395 | ||||||||||||||||||
| Cross-references | |||||||||||||||||||
| Cell line collections (Providers) | ATCC; CCL-185IG | ||||||||||||||||||
| Cell line databases/resources | cancercelllines; CVCL_JK07 | ||||||||||||||||||
| Encyclopedic resources | Wikidata; Q54606944 | ||||||||||||||||||
| Entry history | |||||||||||||||||||
| Entry creation | 15-May-2017 | ||||||||||||||||||
| Last entry update | 19-Dec-2024 | ||||||||||||||||||
| Version number | 12 | ||||||||||||||||||